Senior Director, Market Access, Europe Central Region

About BridgeBio Pharma, Inc.

BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.

Who We Are

BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — with experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth.

At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world.

To learn more about our story and company culture, visit us at https://bridgebio.com

What You'll Do

You will report to the General Manager, Europe Central Region and work closely with international Market Access, and local, regional and global Medical Affairs, as well as with our local field-based colleagues, to drive strategic initiatives that support BridgeBio’s mission of delivering transformative medicines to patients with genetic diseases and genetically driven cancers.

Your primary purpose will be to secure timely, sustainable patient access to the company’s first products by shaping the value narrative, and leading pricing and reimbursement strategy and execution of related dossier, negotiation and cost coverage application work. In this role you ensure we meet our Market Access ambitions aligned with clinical value and global pricing interdependencies.

You will also be a core member of the extended International Market Access team, bringing the voice of the country to the international discussion and decision-making process.

This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact. The ideal candidate combines deep expertise in Market Access related processes for Germany, Austria and Switzerland in the context of introducing a biotech for the first time. You are eager to make a remarkable contribution to a disease space in pre-launch and launch phase in a rare disease and orphan condition with strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.

Responsibilities

• Develop and execute the Central Europe Region market access priorities, including pricing, reimbursement, and launch sequence, aligned with global and regional frameworks

• Lead HTA and payer engagement strategy – with a strong focus on AMNOG, ensuring early, proactive dialogue with national and regional decision-makers to anticipate requirements and reduce access risk

• Own country value dossier strategy and adaptation: incl. comparator selection, evidence gaps, risk mitigation. Thereby ensuring high-quality, locally relevant submissions delivered on time and supporting favourable reimbursement outcomes

• Define and implement pricing strategy, including list price, net price corridors, and contracting principles, while protecting long-term value and portfolio optionality

• Coordinate cross-functionally with Medical Affairs, Commercial, Regulatory, and Finance to align evidence generation, access strategy, and launch readiness, as well as post-launch accounting of rebates and related accruals

• Develop, implement and maintain compliant incentive structures for buying groups in Germany

• Assess potential and advocate for cost coverage and tailored solutions for individual SHIs in Germany

The above job description documents the general nature and level of work but is not intended to be an exhaustive list of activities, duties, and responsibilities required of job incumbents. Therefore, job incumbents are expected to perform all other duties as assigned or required, as training and experience allow.

Where You'll Work

This is a Germany-based role. We anticipate travel within Germany (focus) for KOL meetings and HTA process attendance, Austria, Switzerland (for internal alignment and engagement at our international office in Zug). Regular local team meetings and designated office location in Germany is Munich.

Who You Are

• At least 5 years leading HTA submissions & pricing negotiations in the DACH region, in the context of rare diseases and orphan conditions

• Profound knowledge of the German, Austrian and Swiss healthcare systems & regulations

• Experience in generating relevant data for HTA submission & pricing negotiations, with a relevant network of agencies for related work and support

• Comfortable with presenting convincingly at senior levels & to external thought leaders

• Proven experience in project management of multidisciplinary teams (including external providers)

• Demonstrated ability to organise and execute plans against objectives in a semi-autonomous environment while working effectively in a cross-functional team environment

• Knowledge of product commercialisation processes. Hands-on and solution oriented when it comes to setting up necessary process and documentation

Rewarding Those Who Make the Mission Possible

We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return. 

• Market leading compensation 

• Hybrid work model - we value your flexibility in how you work, but encourage time in the office to strengthen our culture, collaboration, and sense of community

• We provide career development through regular feedback, continuous education and professional development programs

• We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities